Results 221 to 230 of about 210,920 (352)

Designing for Degradation: Transient Devices Enabled by (Nano)Cellulose

Advanced Materials, EarlyView.
Recent progress in transient devices enabled by (nano)cellulosic materials is reviewed. Transiency mechanisms, advantages of nanocelluloses, and a suite of applications are discussed. A circular thinking approach coupled with life cycle assessment is applied to critically revisit the potential, advantages, and challenges of nanocellulose‐enabled ...
Lucas J. Andrew, Erlantz Lizundia, Mark J. MacLachlan   +2 more
wiley   +1 more source

Population interest in and adequacy of the information on the safety of antineoplastic agents in the Spanish edition of Wikipedia. [PDF]

PLoS One
Climent-Ballester S, García-Salom P, Sanz-Valero J.   +2 more
europepmc   +1 more source

Nested Case-Control Study Utilizing MID-NET® on Thrombocytopenia Associated With Pegfilgrastim in Patients Treated With Antineoplastic Agents. [PDF]

Clin Pharmacol Ther, 2021
Kajiyama K, Ishiguro C, Ando T, Kubota Y, Kinoshita N, Oniyama Y, Iguchi T, Uyama Y.   +7 more
europepmc   +1 more source

Taxol, a microtubule-stabilizing antineoplastic agent, differentially regulates normal and tumor-bearing host macrophage nitric oxide production

, 1997
David W. Mullins, David G. Alleva, Carol J. Burger, Klaus D. Elgert   +3 more
openalex   +1 more source

Digitonin‐Loaded Nanoscale Metal–Organic Framework for Mitochondria‐Targeted Radiotherapy‐Radiodynamic Therapy and Disulfidptosis

Advanced Materials, EarlyView.
A mitochondria‐targeted cationic nanoscale metal organic framework shows strong radiotherapy‐radiodynamic therapy effects and selectively releases digitonin in acidic tumor microenvironments to induce disulfidptosis of cancer cells and downregulate immune checkpoints in cancer and T cells, thereby eliciting strong antitumor immunity to effectively ...
Wenyao Zhen, Yingjie Fan, Tomas Germanas, Langston Tillman, Jinhong Li, Abigail L. Blenko, Ralph R. Weichselbaum, Wenbin Lin   +7 more
wiley   +1 more source

Deactivation to antineoplastic agents

, 2015
Petrausch, U, Pircher, M, Reding, Daniel, Ballmer-Weber, B K, Pestalozzi, Bernhard C   +4 more
openaire   +2 more sources

Psychometric properties of instruments for assessing adherence to oral antineoplastic agents: a COSMIN systematic review. [PDF]

PeerJ
Sun M, Huang K, Liu S, Fang C, Yang L.
europepmc   +1 more source

Pulmonary toxicities of molecular targeted antineoplastic agents: a single-center 10-year experience. [PDF]

Korean J Intern Med, 2021
Lee MY, Yoon SY, Kim KH, Lee N, Kim HY, Hwang JH, Won JH.   +6 more
europepmc   +1 more source

IMMUNOTOXIC EFFECTS OF A NEW ANTINEOPLASTIC AGENT S-1 IN MICE : COMPARISON WITH S-1, UFT AND 5-FU

, 1996
Y Kouchi, Yasuhiro Maeda, Hidetaka Morinaga, A Ohuchida   +3 more
openalex   +2 more sources

Rational Design of Metal–Organic Frameworks for Pancreatic Cancer Therapy: from Machine Learning Screening to In Vivo Efficacy

Advanced Materials, EarlyView.
This work explores the MOF landscape to select a single, optimal candidate for successfully delivering cancer drugs (gemcitabine, paclitaxel, SN‐38) into tough pancreatic tumors. Machine learning and simulations guide this search, demonstrating colloidal stability, excellent biocompatibility, cellular uptake, and sustained release.
Francesca Melle, Dhruv Menon, João Conniot, Jon Ostolaza‐Paraiso, Sergio Mercado, Jhenifer Oliveira, Xu Chen, Bárbara B. Mendes, João Conde, David Fairen‐Jimenez   +9 more
wiley   +1 more source